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ABSTRACT Scyliorhinin I, a linear decapeptide, is the only known tachykinin that shows high afﬁnity for both NK-1 and NK-2
binding sites and low afﬁnity for NK-3 binding sites. As a ﬁrst step to understand the structure-activity relationship, we report the
membrane-induced structure of scyliorhinin I with the aid of circular dichroism and 2D-1H NMR spectroscopy. Sequence
speciﬁc resonance assignments of protons have been made from correlation spectroscopy (TOCSY, DQF-COSY) and NOESY
spectroscopy. The interproton distance constraints and dihedral angle constraints have been utilized to generate a family of
structures using DYANA. The superimposition of 20 ﬁnal structures has been reported with backbone pairwise root mean-
square deviation of 0.38 6 0.19 A˚. The results show that scyliorhinin I exists in a random coil state in aqueous environments,
whereas helical conformation is induced toward the C-terminal region of the peptide (D4-M10) in the presence of dodecyl
phosphocholine micelles. Analysis of NMR data is suggestive of the presence of a 310-helix that is in equilibrium with an a-helix
in this region from residue 4 to 10. An extended highly ﬂexible N-terminus of scyliorhinin I displays some degree of order and
a possible turn structure. Observed conformational features have been compared with respect to that of substance P and
neurokinin A, which are endogenous agonists of NK-1 and NK-2 receptors, respectively.
INTRODUCTION
Scy I is a linear decapeptide with amino acid sequence Ala-
Lys-Phe-Asp-Lys-Phe-Tyr-Gly-Leu-Met-NH2. On the basis
of its abilities to contract isolated longitudinal smooth
muscle from the guinea pig ileum, Scy I was ﬁrst puriﬁed
from an extract of the intestine of an elasmobranch ﬁsh,
Scyliorhinus canicula (European common dogﬁsh; Conlon
et al., 1986). Due to the presence of a highly conserved
C-terminal amino acid sequence, Phe-Xaa-Gly-Leu-Met-NH2,
Scy I joins the tachykinin family of neuropeptides, which
represents one of the largest peptide families described in
the animal kingdom. The earliest known members of this
family are the mammalian tachykinins SP, NKA, and
NKB followed by tachykinins from nonmammalian sources
physalaemin, eledoisin, and others. The primary structure of
Scy I has 50% identity to physalaemin (seven residues),
NKA (six residues), and SP (ﬁve residues). These similarities
are concentrated mainly on the C-terminal part, ‘‘message
domain’’ of the peptides that are considered to be important
in receptor interaction. SP: R P K P Q Q F F G L M NH2;
NKA: H K TD S F VG LMNH2; Phys: B A D P NK F YG
L M NH2; Scy I: A K F D K F Y G L M NH2.
In mammals, tachykinins have been shown to elicit a wide
array of activities such as powerful vasodilatation, hyper-
tensive action, and stimulation of extravascular smooth
muscle and are known to be involved in variety of clinical
conditions, including chronic pain, Parkinson’s disease,
Alzheimer’s disease, depression, rheumatoid arthritis, irrita-
ble bowel syndrome and asthma (Khawaja and Rogers,
1996). This broad spectrum of action of tachykinins is
attributed to the lack of selectivity of tachykinins to their
receptors. Three distinct G-protein coupled receptor sub-
types have been cloned and characterized for tachykinins
(Hanley and Jackson, 1987; Masu et al., 1987; Nakanishi,
1991) designated as NK1, NK2, and NK3. All tachykinins
interact with all the three receptor subtypes with SP pre-
ferring NK1, NKA preferring NK2, and NKB preferring
NK3. Considerably more is known about the actions of Scy I
in mammalian systems than in their own species. Compet-
itive binding studies have shown that Scy I is a high-afﬁnity
agonist for both the mammalian NK1 and NK2 tachykinin
receptors and possess 50–250 times reduced afﬁnity for NK3
receptor. The binding afﬁnity of Scy I is as high as that of
endogenous ligands SP and NKA for NK1 and NK2, re-
spectively (Beaujouan et al., 1988; Buck and Krstenansky,
1987). This property of Scy I makes it a valuable tool for
further research on tachykinin receptors. Elucidation of the
membrane bound conformation of this dual selective agonist
is expected to be helpful in understanding the structure-
activity relationship and developing efﬁcient drugs.
Bioactive conformation of tachykinin neuropeptides has
been extensively investigated using high-resolution NMR,
CD, and infrared spectroscopy. Solution structure for SP,
NKA, NKB, physalaemin, eledoisin, and various naturally
derived or synthetic analogs has been reported in various
membranemimetic solvents (Ananthanarayanan andOrlicky,
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1992; Chandrashekar and Cowsik, 2003; Chandrashekar
et al., 2004; Convert et al., 1988, 1991; Cowsik et al., 1997;
Grace et al., 2001, 2003; Horne et al., 1993; Mantha et al.,
2004; Seelig, 1992; Whitehead et al., 1998). Only a few
studies have been reported on the structure of Scy I. A solu-
tion conformational study for Scy I and its analogs with
conformational constraints has been reported in water and
DMSO-d6 using a combination of CD, 2D NMR, and
theoretical conformational analysis (Klaudel et al., 2000;
Rodziewicz-Motowidlo et al., 2000). Their results showed
that the 3D structure of Scy I was rather ﬂexible, whereas
the presence of a local constraint (MePhe7) signiﬁcantly
rigidiﬁed the whole molecule. To date, none of the reported
data deals with the high-resolution structure of Scy I. Binding
of Scy I to its receptor occurs in the membrane environment.
Membrane is proposed to induce a speciﬁc conformation to
the peptide backbone of Scy I before interacting with its
receptor, and this conformational alteration should be an
essential step for the recognition by the receptor.
In this study, we report the 3D structure of Scy I in DPC,
one of the well-characterized model membrane systems
(Opella, 1997), using 2D NMR spectroscopy. CD spectros-
copy has been used to explore secondary structural features
of Scy-I in different membrane mimetic environments,
including 2, 2, 2-TFE, TFE/water mixtures, SDS, DPC
micelles, and in the presence of calcium ions. We also dis-
cuss the mechanism of interaction of Scy I with membranes
and the structural requirements for its function.
MATERIALS AND METHODS
Materials
Scy I (AKFDKFYGLM-[NH2]) was custom synthesized by Princeton
Biomolecules (Langhorne, PA). The purity of peptide reported by HPLC
analysis was.98%. Perdeuterated DPC (d38) was obtained from Cambridge
Isotope Laboratories (Andover, MA). NMR reagents were obtained from
Aldrich Chemical Company (Milwaukee, WI). TFE, SDS, and CaCl2 were
obtained from Sigma (St. Louis, MO) in the highest available purity.
CD spectropolarimetry
CD spectra (190–250 nm) of the peptide were recorded on a Jasco (Tokyo,
Japan) J-720 spectropolarimeter. The instrument had been calibrated
previously for wavelength using benzene vapor and for optical rotation
using d-10-camphorsulphonic acid. A cell with a path length of 1 mm was
used. All the experiments were carried out at room temperature. The
parameters used were as follows: bandwidth, 1 nm; step resolution, 0.25 nm;
scan speed, 50 nm/min; response time, 0.2 s. Each spectrum was obtained
after an average of four scans. The peptide concentration was typically 109
mM in DPC, sodium phosphate buffer pH 7.2, various ratios of TFE/water
mixture, and SDS micelles. Ca21 titrations were carried out using aliquots of
CaCl2 in TFE solution so as to get molar ratios (Ca
21: peptide conc.) of 1:1,
5:1, 10:1, 15:1, and 20:1. Before calculation of the ﬁnal ellipticity, all spectra
were corrected by subtraction of respective spectra obtained for peptide-free
samples (containing only membrane mimetic solvents). Spectra were then
smoothened using fast Fourier transform. CD intensity is expressed in terms
of molar ellipticity ([u], expressed in degrees cm2mol1) according to the
following equation,
½u ¼ umdeg=lC;
where umdeg is the measured ellipticity in millidegrees, l is the cell path
length in cm; and C is the molar concentration of the protein or peptide.
Analysis of CD data
Quantitative estimations of the secondary structure contents were made
using the CDPRO software package, which includes the programs
CDSSTR, CONTINLL, and SELCON 3 (http://lamar.colostate.edu/
;sreeram/CDPro; Sreerama et al., 1999; Sreerama and Woody, 1994).
On analysis of the CD spectra with these three programs, CDSSTR gave
rise to a best ﬁt with the lowest root mean-square deviation (RMSD)
between experimentally derived and calculated points whereas SELCON 3
and CONTINLL gave negative fractions in some calculations. The results
tested with a reference set of 42 proteins are reported in Tables 1 and 2.
Other reference protein sets, such as 29, 37, 43, and 48 were also tested and
gave rise to comparable results.
NMR spectroscopy
The NMR samples were prepared by dissolving 3 mg of Scy I in;0.5 ml of
water (90% H2O, 10% D2O, pH 4.5). The experiments in lipid environment
were performed with an identical peptide sample to which 40 mg of per-
deuterated DPC was added, yielding in solution a lipid concentration of 200
mM, which is well above the critical micellar concentration (1mM). Some
preliminary 1D spectra were recorded at different temperatures (290–320 K).
The phase sensitive homonuclear 2D DQF-COSY, TOCSY, NOESY,
and ROESY experiments at 315 K were performed using a time-proportional
phase incrementation method (Marion and Wu¨thrich, 1983). For these
experiments, 512 transients with 2K complex data points were collected for
each of the increments with a relaxation delay of 1.5 s between successive
transients, the data along the t1 dimension were zero ﬁlled, and the resultant
1K data were subjected to 2D-FT. A TOCSY experiment was performed
using 100 ms, MLEV-17 spin-lock mixing pulse. NOESY experiments were
performed at mixing times of 100, 150, 200, and 250 ms, and a ROESY
experiment at 200 ms mixing time. All NMR spectra were recorded on
a Bruker (Zurich, Switzerland) DRX-500 spectrometer. The NMR spectra
were processed using XWINNMR software on a Silicon Graphics fuel
workstation (SGI, Mountain View, CA).
Structure calculation
Distance constraints were extracted from the NOESY spectra with 150 ms
mixing time. All the NOE intensities were classiﬁed as strong, medium, and
weak and were converted to the corresponding upper bound interproton
distance restraints of 2.7, 3.5, and 5.0 A˚, respectively. A total of 94 NOE
constraints (42 intraresidue, 26 i, i1 1, 15 i, i1 2, 8 i, i1 3, and 3 i, i1 4)
were originally applied for structure calculation using DYANA (Gu¨ntert
et al., 1997). 3JHNa-coupling constants were obtained from high resolution
1D spectra and converted to dihedral angles by applying the Karplus
relationship (Pardi et al., 1984). A total of 50 structures were calculated by
DYANA out of which 20 conformers with lowest target function value were
consequently subjected to restrained energy minimization.
RESULTS
Secondary-structural studies of Scy-I by
CD spectropolarimetry
To investigate the secondary structure of Scy I in various
membrane mimetic solvents, CD spectra were recorded in
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phosphate buffer pH 7.2, TFE/water mixture (10%–90%),
SDS micelles (4 mM–64 mM) and DPC micelles (5 mM). As
shown in Fig. 1, in an aqueous environment, Scy I exhibits
a strong negative band at 195 nm and a weak positive band
around 218 nm, characteristic of random coil conformation
(Woody, 1992). However, Scy I adopts helical conformation
with increasing titers of TFE. The helical content is further
increased to 68.3% in 64 mM SDS and 71.3% in 5 mM DPC
as compared to 56.8% in 90% TFE. The CD data analyzed by
using CDPRO (CDSSTR) software is in good agreement
with the values of two parameters, R1 and R2, which are
independent of inaccuracies in determined peptide concen-
tration, as well as those caused by small shifts in wavelength
(Bruch et al., 1991). For a random structure, R1 is positive and
R2 is close to zero. On the other hand, in a highly helical state,
R1 will be close to 2 and R2 will approach 1 (Bruch et al.,
1991; Rizo et al., 1993). Thus the CD results (Table 1) in-
dicate that Scy I associates with TFE, SDS, and DPCmicelles
undergoing a conformational transition from a prevalently
random coil state (in water) to an a-helical state.
The interaction of Ca21 with Scy I was studied by
monitoring changes in CD spectra of the peptide in a 190–
250 nm range to observe alteration in the secondary structure
of the peptide. CD spectral features of Scy I indicate no
appreciable secondary structure in water (Fig. 1). No sig-
niﬁcant changewas observed even on addition of over 2molar
excess ofCa21 to a solution of Scy I inwater (data not shown).
However, a substantial change in CDoccurred on treating Scy
IwithCa21 in TFE.As seen in Fig. 2, there is an increase in the
helical content on addition of Ca21 (up to a ratio of 5:1) as
compared to 100% TFE. There is a subsequent decrease on
further addition of calcium. This effect is nonspeciﬁc and is
perhaps due to the destabilization of the structure by the high
ionic strength of calcium solution used. Secondary structural
features obtained are summarized in Table 2.
Resonance assignments
All proton resonances were assigned using the standard
sequential assignment strategy (Wu¨thrich, 1986). TOCSY
and DQF-COSY spectra were used to assign spin systems of
most of the amino acid residues. Aromatic residues were
identiﬁed using NOE connectivities between Cb protons and
aromatic ring protons. Complete sequence speciﬁc assign-
ments were obtained by direct comparison of TOCSY and
NOESY spectra (Figs. 3 and 4).
On the basis of observation of a relatively small number
of interresidue crosspeaks in the ROESY spectra, it was
concluded that Scy I essentially adopted a random coil
conformation in water. Also the CD results indicated that
Scy I was unstructured in aqueous media. Hence no further
analysis was carried out in water.
Structure calculations in DPC micelles
A summary of the interresidue sequential and medium-range
NOEs is provided in Fig. 5. The presence of several NH-NH
FIGURE 1 CD spectra of Scy I in buffer, 64 mM SDS micelles, 90% TFE
and DPC micelles.
FIGURE 2 CD spectra of calcium titration of Scy I. Different spectra in
the ﬁgure represent various ratios of calcium to peptide A: 100% TFE; B:
1:1; C: 5:1; D: 10:1; E: 15:1; and F: 20:1, respectively.
TABLE 1 Secondary structural analysis of the Scy I peptide in
various membrane-mimicking environments using CDSSTR
with a 42-reference protein set*
Secondary structure (%)*
Environment Helix Strand Turn Unrd RMSD R1y R2y
Phosphate buffer,
pH 7.2
0 32.8 15.9 52.7 0.134 4.67 0.11
90% TFE 56.8 15.8 13.4 13.4 0.100 1.01 0.85
64 mM SDS 68.3 11.9 12.6 6.3 0.062 1.10 0.90
5 mM DPC 71.3 9.4 7.8 10.1 0.99 1.96 0.95
*For convenience of data interpretation, we added the distorted and regular
components of both helical and strand secondary-structural elements to-
gether to obtain overall helical and strand structures in both Tables 1 and 2.
yHere R1 is the ratio of the intensity of the maximum between 190 and 195
nm and the intensity of the minimum between 200 and 210 nm, and R2 is
the ratio of the intensity of the minimum near 222 nm and the intensity of
the minimum between 200 and 210 nm.
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connectivities, together with aH-NHi13 and aH-bHi13
connectivities suggests the presence of some helical
elements from residue 2–10. Medium range NOE connec-
tivities, 5 dNN (i, i 1 2), 8 daN (i, i 1 2), along with daN (i,
i1 3) support the presence of a 310-helix from residue 4–10,
which is also supported by the negative chemical shift index
(Wishart et al., 1992) and values of coupling constants for
these residues. The presence of some population of a-helix is
supported by the observation of daN (i, i 1 4) connectivity
between residues F3-Y7, K5-L9, and F6-M10, but the
relative strengths of the sequential NOEs, particularly near
both termini, are not representative of a well-deﬁned a-helix.
For the region near the N-terminus, the possibility of a b-turn
seems to be more pronounced, as seen by the absence of
dab (i, i 1 3) crosspeaks. This is further supported by the
presence of Asparagine at Position 4, which has the helix
breaking tendency. Analysis of NMR data is suggestive of
the presence of a 310-helix that is in equilibrium with an
a-helix in this region from residue 4 to 10.
All measurable 3JHNa-coupling constants for Scy I are
in the range of 3–6 Hz, with the exception of L9 and M10
(8 and 9.2 Hz, respectively). Higher values of 3JHNa (.6 Hz)
for L9 and M10 can be attributed to the fraying of the helix
at the terminus and susceptibility of short, linear peptides to
undergo conformational averaging (Dyson and Wright,
1991). Estimates of the fraction of molecules possessing
folded conformation can be obtained by the analysis of aH-
NHi 1 1 and NH-NH NOE intensities using the procedure
of Bradley et al. (1990). In this analysis, we use the term
‘‘folded’’ in preference to ‘‘helix’’ since reverse turn and
helix structures can produce similar NOE intensities. A
calculation based on NOE intensities conﬁrms a high helical
content (84%) over residues 4–10. The value is somewhat
higher than that indicated by the CD data (71%), but this may
be rationalized by potential difﬁculties in the CD spectra of
small peptides, where dichroism of aromatic amino acids can
mask the CD signal of ‘‘structured’’ conformers, especially
for short helices.
Generation of the 3D structure
A 3D structure of Scy I was obtained using a torsion angle
dynamics algorithm for NMR applications, DYANA
(Gu¨ntert et al., 1997). A total of 91 NOE distance constraints
and angle constraints from measured 3JHNa were used as
input. Initially 50 structures were generated, out of which 20
conformers with the lowest target function values (i.e., least
violations of experimental restraints and van der Waals
distances) were chosen for further restrained energy min-
imization. The resulting structures are shown in Fig. 6, after
superimposing the backbone atoms. The backbone pairwise
RMSD for all residues is 0.38 A˚ with standard deviation of
0.19 A˚ and for all heavy atoms is 1.99 A˚ with standard
deviation of 0.40 A˚. The lowest RMS differences are seen for
residues 5–9, where the folded structures determined from
the NOE data are best deﬁned.
The Ramachandran plot for all 20 reﬁned structures
(included in the supplementary material) indicates that the
backbone dihedral angles consistently lie in the a-region of
the plot and are within the allowed ranges. The average values
of F and C angles for the helix region are 74(69),
27(67) and for the turn are 79(66), 22(64). The
shifted backbone conformation for the C-terminal residue
(F, C angles: 90, 0) compared to the rest of the helix is
a characteristic feature of 310-helices. The deviation can be
attributed to the release of electrostatic repulsion between the
carbonyl oxygen atoms at the two C-terminal residues and
further stabilization (due to a more linear geometry) of an
intrahelical hydrogen bond. Measurements of C¼Oi, NHi 1 3
versus C¼Oi, NHi 1 4 distances along the stretch of residue
FIGURE 3 The NH-a,b,g region of the 500 MHz NOESY spectrum of
Scy I in the presence of membrane mimetic solvent (DPC), recorded with
a mixing time of 150 ms.
TABLE 2 Effect of calcium concentration on the conformation
of Scy I using CDSSTR with a 42-reference protein set
Secondary structure (%)
Environment
(Calcium:
peptide ratio) Helix Strand Turn Unrd RMSD R1 R2
100% TFE 56.8 15.8 13.4 13.4 0.100 1.01 0.85
1:1 60.2 17.3 12.7 9.5 0.083 1.30 0.865
5:1 62.5 14.3 10.9 12.0 0.084 1.32 0.88
10:1 57.4 20.1 11.6 10.8 0.083 0.22 0.67
15:1 54 14.8 16.3 15.3 0.135 0.20 0.63
20:1 49.8 20.8 9.0 20.5 0.141 0.32 0.20
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4–10 were made, and the i, i1 3 distances were,3.0 A˚ in the
majority (.75%) of structures as compared to i, i 1 4 dis-
tances, suggesting that Scy I has a preference for a 310-helix
over a regular helix.
Results from this study indicate that the Scy I prefers to be
in a random coil conformation in aqueous solution, whereas
part of the N-terminus address domain and the whole of the
C-terminal message domain are folded. The NMR data
suggest the presence of equilibrium between the 310-helix
and the a-helix along the residues 4–10 of Scy I, preceded by
a turn over residues 1–3 of Scy I. In DPC, the structural
equilibrium is biased toward a 310 helix though a small
population of regular a-helix cannot be excluded in the
solution ensemble. The 310-helix exists as the intermediate
between the folding pathway of helices (random coil 4
nascent helix4 310-heilx4 a-helix; Millhauser, 1995). A
recent study on the analysis of the shortest helices explains
the formation of the b-turn might be correlated to the
nucleation step for the formation of both a- and 310-helices
(Pal et al., 2003).
DISCUSSION
Although only a few studies have been reported on the
structure of Scy I, dual equipotent selectivity of Scy I toward
NK1 and NK2 receptors makes it a particularly interesting
peptide for studying the structure-activity relationship.
Important information available on tachykinins is distinctly
different structural and functional behavior of N- and
C-terminals. Available structure-activity relationship studies
indicate that the N-terminal domains of tachykinin peptides
affect the desensitization but not the agonist activities of the
peptides (Cascieri et al., 1992; Vigna, 2001; Zboinska et al.,
1993). On examination of the ability of Scy I to cause rapid
homologous desensitization of the NK1 receptor, it was
found that Scy I caused desensitization similar to that of SP,
and the N-terminal domain of Scy I affected both receptor
signaling and desensitization (Vigna, 2003).
It has been reported that the action of tachykinins is
dependent on extracellular calcium concentration (O’Rior-
dan et al., 2001; Pernow, 1983) and that the calcium bound
conformation of tachykinins is required for receptor
activation (Ananthanarayanan and Orlicky, 1992). Anantha-
narayanan and co-workers studied conformational determi-
nants for Ca21 binding by short synthetic peptides in
nonpolar solvents (Qi et al., 2000) and reported that even in
the absence of acidic side-chain groups, cation binding to the
polar groups in the backbone was a facile process in low
dielectric medium. The main conformational requirement
appeared to be the ability to adopt a folded structure like
a helix or turn in nonpolar medium. Many tachykinins
including Scy I fulﬁll this criterion. Structural studies on Scy
I suggested induction of folded conformation in TFE, SDS,
and DPC micelles. We have in this study made use of these
observations as the basis for examining the structure of Scy I
in terms of its interaction with calcium in TFE using CD.
FIGURE 4 The NH-NH region of the 500 MHz
phase-sensitive NOESY spectrum of Scy I in the
presence of membrane mimetic solvent (DPC), re-
corded with a mixing time of 150 ms.
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The results of our preliminary study demonstrate a speciﬁc
interaction of Scy I with calcium in TFE. CD studies on
calcium titrations show that the helicity increases with
increasing concentrations of calcium and that the calcium
bound conformation of Scy I is considerably different from
that of a free Scy I. It is of interest to note that a similar
situation exists in the case of SP, a tachykinin, and two other
peptide hormones—insulin and glucagons (Ananthanar-
ayanan et al., 1997; Brimble and Ananthanarayanan, 1992,
1993; Qi et al., 2000). This suggests that speciﬁc constraints
may be imposed on the Scy I structure on its interaction with
calcium at low concentrations, which may play a role in the
bioactive conformation of the peptide and its interaction with
the receptor. At higher concentrations, calcium seems to be
having a nonspeciﬁc destabilizing effect on the structure of
the peptide. The destabilizing effects of calcium at high ionic
strength have also been observed in some studies (Pastrana-
Rios et al., 2002).
Previous studies have indicated that diverse hormones
such as glucagons, SP, NPG, Bombesin, and GnRh
(Ananthanarayanan et al., 1998; Qi et al., 2000) have the
ability to bind divalent cation in lipid mimetic solvents and to
transport calcium across the synthetic liposomes in aqueous
buffers. The ionophoretic ability seems to reside in the
C-terminal segment containing the Met-Leu sequence. In
light of a proposal on the importance of calcium in dictating
the bioactive conformation of the peptide hormones
(Ananthanarayanan, 1991; Ananthanarayanan et al., 1997,
1998; Pernow, 1983), in general we would expect the
C-terminal of Scy I to insert into membrane with the bound
calcium and interact with the receptor to form a ternary
complex between hormone, receptor, and cation. The
speciﬁcity of binding can be determined only after a detailed
study with different analogs has been undertaken. More
work is needed before the relevance of these observations to
the in vivo action of the peptide is understood.
Summarizing the NMR-derived structure, the amidated
C-terminus of Scy-1 inDPC comprises a 310-helix or turn-like
elements with some possible fraying of the helix terminus.
The ‘‘address’’ segment of Scy I, although undergoing greater
conformational averaging than the ‘‘message’’ domain, also
retains substantial conformational order in DPC. This order
may be interpreted as a loosely deﬁned turn or an unstable
continuation of the 310-helix along the message domain. The
presence of a turn in the N-terminus preceding the helical core
correlates well with the conformational features adopted
by NK2 agonists like NKA, NPg, eledoisin, and Kassinin
(Chandrashekar and Cowsik, 2003; Chandrashekar et al.,
2004; Grace et al., 2001, 2003). It has been proposed that
selective agonists for the NK3 receptor prefer to adopt an
a-helical conformation (Mantha et al., 2004; Wilson et al.,
1994). The presence of a turn preceding the helical core
explains the reduced afﬁnity of Scy I toward the NK3
receptor.
The solution conformation of Scy I bound to DPC
micelles determined in this study supports various structure-
activity and receptor-ligand interaction data available on
NK1/NK2 agonists. (Cascieri et al., 1992; Patacchini et al.,
FIGURE 5 The NOEs that are important to characterize the secondary
structure of Scy I in the presence of DPC micelles. Solid triangles refer
to a coupling constant of 4 to 5 Hz and solid circles to 6 Hz and above.
FIGURE 6 Stereo view showing the superimposition of the backbone
atoms of Scy I for 20 structures generated by DYANA.
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1993a,b; Seelig, 1992; Seelig et al., 1996; Whitehead et al.,
1998). As seen in Fig. 7, the C-terminus of Scy I presents two
different faces to the receptor: a hydrophobic face comprised
of Phe 6, Leu 9, Met 10 side chains on one side and
a hydrophilic face comprised of Lys 5, Tyr 7, and Gly 8 side
chains on the other. This amphipathic nature of the helix at
the C-terminus is characteristic of NK-1 receptor agonists
(Seelig, 1992; Seelig and Macdonald, 1989; Seelig et al.,
1996). Moreover, the presence of an aromatic residue at
Position 7 from the N-terminus appears to determine or
modify selectivity of the peptide for the NK1 receptor
(Severini et al., 2002). In support of this is the observation
that the Tyr residue at Position 7 is important in determining
the potency and selectivity of Scy I at the tachykinin
receptors, and the introduction of Phe in Scy I provides the
molecule with higher selectivity for the NK1 receptor
(Patacchini et al., 1993a,b). Scy I contains two Lys residues
that would result in a more favorable interaction with the
anionic ﬁxed-charge compartment of the plasma membrane
and greater access to the NK-1 and NK-2 receptors
(Schwyzer, 1987). It can be proposed that the ‘‘nonpolar’’
nature of the Tyr side chain at Position 7 of Scy I confers
selectivity for NK2 receptor binding, whereas the aromatic
ring of Tyr is important for NK-1 binding. Absence of a Pro
residue at Position 4 from the N-terminus (as present in the
majority of NK1 receptor agonists), adjacent to the crucial
neutral or basic residue occupying Position 3 (‘‘Lys’’ in SP,
NKA, and Scy I), can be considered favorable for the
binding of NK2 receptors. Aspartate residue in Scy I,
analogous to residue 5 in SP and residue 4 in NKA, may be
involved in an ionic interaction, thus contributing to the
binding energy as proposed by Cascieri and Buck for NK2
agonists (Buck and Shatzer, 1988; Cascieri et al., 1992). We
propose that the charged amino acid residues, Lys 2 and Asp
4, of the N-terminus region act as anchoring points, main-
taining peptide conformation and positioning the C-terminus
within the transmembrane region.
Since the structural features of the peptide ligand have been
determined in isolation, there could be conformational
changes to the structure upon interaction with the receptor.
However these structural features, which seem to be essential
for the biological activity, will probably be maintained until
Scy I approaches its receptor. The elucidation of the 3D
structure is particularly important for the development of
agonist/antagonists with regard to the NK-1 and NK-2
receptors with potential for synergistic pharmacological
effects.
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